NCT06048445

Brief Summary

Liver transplantation is an effective method for treating end-stage liver disease and metabolic diseases in children. With the advancement of surgical techniques and the improvement of perioperative management, the survival rates of patients and grafts after liver transplantation have significantly improved. However, the complication of biliary stenosis after transplantation is as high as 7.3% -33.3%, and in severe cases, it can even lead to graft failure and patient death. Therefore, the occurrence of biliary stenosis after liver transplantation seriously affects the quality of life of children, increases the economic burden on families, and urgently needs to find effective methods to reduce the occurrence of this complication. Based on the clinical practice of our center, we believe that the placement of biliary external drainage stents has the following advantages: 1 Reduce intrahepatic biliary pressure and reduce the occurrence of postoperative biliary fistula; 2. The stent has a supporting effect and can maintain the open state of the bile duct; 3. By external drainage, the quality of bile secretion by the liver can be evaluated; 4. Provide a pathway for cholangiography. However, placing external biliary drainage may also pose certain risks, including increasing surgical procedures, stent detachment causing biliary fistula, and increasing the risk of infection. This study aims to observe the effect of placing external biliary drainage stents on biliary stricture after liver transplantation in children. The aim is to evaluate the preventive effect of external biliary drainage stents on biliary intestinal anastomotic stenosis after liver transplantation in children, and to provide evidence-based evidence for reducing biliary complications in children.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for all trials

Timeline
20mo left

Started Feb 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Feb 2023Dec 2027

Study Start

First participant enrolled

February 7, 2023

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

September 9, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 21, 2023

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

August 11, 2025

Status Verified

August 1, 2025

Enrollment Period

3.9 years

First QC Date

September 9, 2023

Last Update Submit

August 5, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • duct-jejunum anastomotic stoma stricture

    number of participants with duct-jejunum anastomotic stoma stricture after liver transplantation

    one year

Secondary Outcomes (1)

  • biliary tract infection

    one year

Study Arms (2)

Biliary Drainage Stent group

placement of Biliary Drainage Stent in pediatric liver transplantation

Device: intraoperative plancement of Biliary Drainage Stent

no Biliary Drainage Stent group

no placement of Biliary Drainage Stent in pediatric liver transplantation

Interventions

plancement of Biliary Drainage Stent in liver transplantation of pediatric patients

Biliary Drainage Stent group

Eligibility Criteria

Age1 Year - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

pediatric patients need liver transplantation

You may qualify if:

  • The patient underwent liver transplantation surgery at the First Affiliated Hospital of Zhejiang University School of Medicine;
  • Age ≤ 6 years old;
  • First liver transplantation;
  • Willing to sign an informed consent form.

You may not qualify if:

  • \- Existence of mental illnesses that can affect cognition and coordination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the First Affiliated Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, 310003, China

RECRUITING

Central Study Contacts

Weili Wang, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy Director of the Department

Study Record Dates

First Submitted

September 9, 2023

First Posted

September 21, 2023

Study Start

February 7, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2027

Last Updated

August 11, 2025

Record last verified: 2025-08

Locations